ERBB2 and breast cancer: In addition, with the exception of the HER2 subtype, and compared to other tumour types, most patients lack a clear oncogenic-addiction driver, which suggests that most HER2-negative breast cancers are the result of the accumulation of several non-sufficient, non-necessary oncogenic alterations1–9.